Skip to content

Clinical trials

Completed Phase 1/2 Colorectal Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Colorectal Neoplasms Phase: Phase 1/2 Status: Completed Clear all

174 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20006
20015
20022
20034
20046
20053
20066
20079
20088
200911
201011
20114
201215
20132
20149
20153
201612
201715
201812
20197
20207
20216
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed174

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb4
National Cancer Institute (NCI)4
Fuda Cancer Hospital, Guangzhou3
Gilead Sciences3
Incyte Corporation3
Isofol Medical AB3
Memorial Sloan Kettering Cancer Center3
Swiss Cancer Institute3
Amgen2
AstraZeneca2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colorectal Neoplasms174
Colonic Neoplasms45
Rectal Neoplasms34
Pancreatic Neoplasms20
Carcinoma, Non-Small-Cell Lung18
Neoplasm Metastasis18
Ovarian Neoplasms17
Breast Neoplasms16
Neoplasms14
Stomach Neoplasms13

Trials

Showing 1 to 25 of 174. Each trial links to its page on Pharma Observatory.

74 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.